These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23515969)

  • 1. Letter to the Editor: comment on the article "estimating the influence of physicians on the underuse of drugs in diabetic nephropathy in Taiwan" by Huang et al, and author's reply.
    Minutolo R; Conte G; De Nicola L
    J Nephrol; 2013; 26(2):417-8. PubMed ID: 23515969
    [No Abstract]   [Full Text] [Related]  

  • 2. Author's reply: To PMID 22641577.
    Hsieh JY
    J Nephrol; 2013; 26(2):417-8. PubMed ID: 23515970
    [No Abstract]   [Full Text] [Related]  

  • 3. Estimating the influence of physicians on the underuse of drugs in diabetic nephropathy in Taiwan.
    Huang LY; Yeh HL; Su S; Wang TC; Hsieh JY
    J Nephrol; 2013; 26(1):16-24. PubMed ID: 22641577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [German Hypertension Society: update on the management of hypertension].
    Aumiller J
    MMW Fortschr Med; 2012 Jan; 154(1):69-70. PubMed ID: 22642011
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country.
    Mennini FS; Marcellusi A; von der Schulenburg JM; Gray A; Levy P; Sciattella P; Soro M; Staffiero G; Zeidler J; Maggioni A; Schmieder RE
    Eur J Health Econ; 2015 Nov; 16(8):909-11. PubMed ID: 26231984
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antihypertensive treatment in type 1 diabetes and diabetic nephropathy].
    Chantrel F; Kolb I; Bouiller M; Hannedouche T
    Nephrologie; 1999; 20(4):203-8. PubMed ID: 10480152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underuse of ACE inhibitors and angiotensin II receptor blockers among patients with diabetic nephropathy in Taiwan.
    Yeh HL; Huang LY; Su S; Yang MC; Wang TC
    Health Policy; 2011 May; 100(2-3):196-202. PubMed ID: 21146895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical strategy for the treatment of hypertension in non-diabetic and diabetic nephropathy in Japan.
    Kanno Y; Okada H; Nakamoto H; Suzuki H
    Contrib Nephrol; 2004; 143():145-58. PubMed ID: 15248362
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antihypertensive treatment in type II diabetes and diabetic nephropathy].
    Chantrel F; Bouiller M; Kolb I; Hannedouche T
    Nephrologie; 2000; 21(2):47-55. PubMed ID: 10798204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in pharmacological management of hypertension in diabetic patients with nephropathy. Effects of antihypertensive drugs on kidney function and insulin sensitivity.
    Baba T; Ishizaki T
    Drugs; 1992 Apr; 43(4):464-89. PubMed ID: 1377114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Descriptive analysis of mail interventions with physicians and patients to improve adherence with antihypertensive and antidiabetic medications in a mixed-model managed care organization of commercial and Medicare members.
    Jing S; Naliboff A; Kaufman MB; Choy M
    J Manag Care Pharm; 2011 Jun; 17(5):355-66. PubMed ID: 21657805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hypertension and antihypertensive treatment on kidney function in diabetic nephropathy.
    Hommel EE
    Dan Med Bull; 1994 Apr; 41(2):167-78. PubMed ID: 8039432
    [No Abstract]   [Full Text] [Related]  

  • 13. What blood-pressure level provides greatest renoprotection in patients with diabetic nephropathy and hypertension?
    Ruggenenti P; Remuzzi G
    Nat Clin Pract Nephrol; 2006 May; 2(5):250-1. PubMed ID: 16932436
    [No Abstract]   [Full Text] [Related]  

  • 14. [Which antihypertensive drugs for diabetic patients? Remembering the organ protective potential!].
    MMW Fortschr Med; 2001 Jul; 143(26-27):54. PubMed ID: 11481919
    [No Abstract]   [Full Text] [Related]  

  • 15. Adherence to medication: the importance of research in primary care.
    Prado JC; Mion D
    Am J Hypertens; 2010 Feb; 23(2):109. PubMed ID: 20087323
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypertension and antihypertensive treatment of diabetic nephropathy.
    Ritz E; Dikow R
    Nat Clin Pract Nephrol; 2006 Oct; 2(10):562-7. PubMed ID: 17003835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan.
    Wu PH; Yang CY; Yao ZL; Lin WZ; Wu LW; Chang CC
    Am J Hypertens; 2010 Feb; 23(2):155-60. PubMed ID: 19927135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study examines prescriptions for hypertension. Physicians adhering to guidelines very well].
    MMW Fortschr Med; 2003 Jun; 145(25):51. PubMed ID: 12891855
    [No Abstract]   [Full Text] [Related]  

  • 19. Obstetric nephrology: pregnancy in women with diabetic nephropathy--the role of antihypertensive treatment.
    Mathiesen ER; Ringholm L; Feldt-Rasmussen B; Clausen P; Damm P
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):2081-8. PubMed ID: 22917698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can two be better than one? Dual RAS blockade in patients with type 2 diabetes and overt nephropathy in the age of ONTARGET and ALTITUDE.
    Lovshin JA; Cherney DZ
    Hypertens Res; 2014 Jan; 37(1):4-6. PubMed ID: 24026039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.